SNX-5422

· Esanex Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for SNX-5422, covering 2012-05-17 to 2019-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL [Phase 1]